| Schedule of Basic and Diluted Earnings Per Share |
|
|
|
Voting common stock
|
|
|
Non-voting common stock
|
|
|
Basic net loss per share:
|
|
|
|
|
|
|
|
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
Allocation of undistributed losses attributable to common stockholders
|
|
$
|
(5,380
|
)
|
|
$
|
(2,105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Denominator
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in basic per share computation
|
|
|
16,379,788
|
|
|
|
6,409,519
|
|
|
Net loss per share, basic
|
|
$
|
(0.33
|
)
|
|
$
|
(0.33
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
Numerator
|
|
|
|
|
|
|
|
|
|
Allocation of undistributed losses for basic computation
|
|
$
|
(5,380
|
)
|
|
$
|
(2,105
|
)
|
|
Reallocation of undistributed losses as a result of conversion of
non-voting to voting common shares
|
|
|
(2,105
|
)
|
|
|
—
|
|
|
Allocation of undistributed losses
|
|
$
|
(7,485
|
)
|
|
$
|
(2,105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Denominator
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in basic per share computation
|
|
|
16,379,788
|
|
|
|
6,409,519
|
|
|
Add: conversion of non-voting to voting common shares outstanding
|
|
|
6,409,519
|
|
|
|
—
|
|
|
Weighted average number of shares used in diluted per share computation
|
|
|
22,789,307
|
|
|
|
6,409,519
|
|
|
Net loss per share, diluted
|
|
$
|
(0.33
|
)
|
|
$
|
(0.33
|
)
|
For the three months ended March 31, 2019, basic and diluted net loss per share is:
|
|
|
Common stock
|
|
|
Basic and diluted net loss per share:
|
|
|
|
|
|
Numerator
|
|
|
|
|
|
Net loss attributable to common stockholders
|
|
$
|
(8,858
|
)
|
|
|
|
|
|
|
|
Denominator
|
|
|
|
|
|
Weighted average number of shares used in basic and
diluted per share computation
|
|
|
1,464,572
|
|
|
Net loss per share, diluted
|
|
$
|
(6.05
|
)
|
|
| Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share |
The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:
|
|
|
As of March 31,
|
|
|
|
|
2020
|
|
|
2019
|
|
|
Convertible preferred stock
|
|
|
—
|
|
|
|
19,356,835
|
|
|
Stock options to purchase common stock
|
|
|
2,657,704
|
|
|
|
1,304,285
|
|
|
Non-vested common stock
|
|
|
1,158,185
|
|
|
|
2,382,651
|
|
|
|
|
|
3,815,889
|
|
|
|
23,043,771
|
|
|